| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 30.870 | 37.780 | 61.523 | 57.598 | 59.249 | 81.402 | 92.799 | 105.268 | 104.405 |
| Total Income - EUR | - | 30.878 | 37.818 | 61.551 | 57.675 | 59.383 | 81.481 | 93.768 | 107.062 | 105.824 |
| Total Expenses - EUR | - | 4.483 | 7.495 | 9.498 | 9.693 | 9.074 | 9.860 | 9.107 | 13.285 | 16.341 |
| Gross Profit/Loss - EUR | - | 26.395 | 30.323 | 52.052 | 47.983 | 50.309 | 71.621 | 84.661 | 93.777 | 89.483 |
| Net Profit/Loss - EUR | - | 25.777 | 29.945 | 51.437 | 47.406 | 49.760 | 70.904 | 83.724 | 92.728 | 86.372 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oncohope Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 823 | 514 | 216 | 0 | 0 | 0 | 16.755 | 13.091 |
| Current Assets | - | 26.365 | 30.059 | 52.206 | 49.181 | 50.932 | 72.070 | 84.985 | 77.259 | 134.082 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.757 | 6.567 | 4.005 | 1.409 | 3.169 | 51.168 | 64.492 | 49.791 | 64.696 |
| Cash | - | 24.609 | 23.492 | 48.201 | 47.772 | 47.762 | 20.902 | 20.493 | 27.468 | 69.386 |
| Shareholders Funds | - | 25.822 | 29.997 | 51.488 | 47.457 | 49.810 | 70.953 | 83.772 | 92.777 | 86.420 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 544 | 885 | 1.232 | 1.940 | 1.122 | 1.117 | 1.213 | 1.238 | 60.753 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncohope Srl